Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, 300020, China.
Tianjin Key Laboratory of Ophthalmology and Visual Science, Tianjin Eye Institute, Tianjin Eye Hospital, Tianjin, 300020, China.
Sci Rep. 2023 Nov 23;13(1):20539. doi: 10.1038/s41598-023-47990-0.
As of 2021, over 2.8 million small-incision lenticule extraction (SMILE) procedures have been performed in China. However, knowledge regarding the selection of intraocular lens (IOL) power calculation formula for post-SMILE cataract patients remains limited. This study included 52 eyes of 26 myopic patients from northern China who underwent SMILE at Tianjin Eye Hospital from September 2022 to February 2023 to investigate the suitability of multiple IOL calculation formulas in post-SMILE patients using a theoretical surgical model. We compared the postoperative results obtained from three artificial intelligence (AI)-based formulas and six conventional formulas provided by the American Society of Cataract and Refractive Surgery (ASCRS). These formulas were applied to calculate IOL power using both total keratometry (TK) and keratometry (K) values, and the results were compared to the preoperative results obtained from the Barrett Universal II (BUII) formula for the SMILE patients. Among the evaluated formulas, the results obtained from the Emmetropia Verifying Optical 2.0 Formula with TK (EVO-TK) (0.40 ± 0.29 D, range 0-1.23 D), Barrett True K with K formula (BTK-K, 0.41 ± 0.26 D, range 0.01-1.19 D), and Masket with K formula (Masket-K, 0.44 ± 0.33 D, range 0.02-1.39 D) demonstrated the closest proximity to BUII. Notably, the highest proportion of prediction errors within 0.5 D was observed with the BTK-K (71.15%), EVO-TK (69.23%), and Masket-K (67.31%), with the BTK-K showing a significantly higher proportion than the Masket-K (p < 0.001). Our research indicates that in post-SMILE patients, the EVO-TK, BTK-K, and Masket-K may yield more accurate calculation results. At their current stage in development, AI-based formulas do not demonstrate significant advantages over conventional formulas. However, the application of historical data can enhance the performance of these formulas.
截至 2021 年,中国已经完成了超过 280 万例小切口透镜切除术 (SMILE)。然而,对于 SMILE 术后白内障患者人工晶状体 (IOL) 屈光力计算公式的选择,相关知识仍然有限。本研究纳入了 2022 年 9 月至 2023 年 2 月在天津医科大学眼科医院接受 SMILE 手术的 26 例北方近视患者的 52 只眼,通过理论手术模型,探讨了多种 IOL 计算公式在 SMILE 术后患者中的适用性。我们比较了三种基于人工智能 (AI) 的公式和美国白内障和屈光手术学会 (ASCRS) 提供的六种常规公式的术后结果。这些公式分别使用总角膜曲率 (TK) 和角膜曲率 (K) 值来计算 IOL 屈光力,并将结果与用于 SMILE 患者的 Barrett Universal II (BUII) 公式的术前结果进行比较。在所评估的公式中,Emmetropia Verifying Optical 2.0 Formula with TK (EVO-TK) 的结果与 BUII 最接近 (0.40 ± 0.29 D,范围 0-1.23 D),Barrett True K with K formula (BTK-K) 的结果为 0.41 ± 0.26 D (范围 0.01-1.19 D),Masket with K formula (Masket-K) 的结果为 0.44 ± 0.33 D (范围 0.02-1.39 D)。值得注意的是,BTK-K (71.15%)、EVO-TK (69.23%) 和 Masket-K (67.31%) 的预测误差在 0.5 D 以内的比例最高,BTK-K 明显高于 Masket-K (p < 0.001)。我们的研究表明,在 SMILE 术后患者中,EVO-TK、BTK-K 和 Masket-K 可能会产生更准确的计算结果。在目前的发展阶段,基于 AI 的公式并没有比常规公式显示出明显的优势。然而,应用历史数据可以提高这些公式的性能。